Seung-Hyeon lee

Mr. Seung-Hyeon lee

Department of Science in Korean Medicine, Kyunghee University, Seoul, Republic of Korea
+1
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
EAEun-Jin An
Eun-Jin An
YKYumi Kim
Yumi Kim
Seung-Hyeon leeSeung-Hyeon lee
Seung-Hyeon lee
SCSeung-Han Choi
Seung-Han Choi
WCWon Seok Chung
Won Seok Chung
Hyeung-Jin JangHyeung-Jin Jang
Hyeung-Jin Jang

6 July 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
HKHyun Min Ko
Hyun Min Ko
Seung-Hyeon leeSeung-Hyeon lee
Seung-Hyeon lee
WJWona Jee
Wona Jee
Ji Hoon JungJi Hoon Jung
Ji Hoon Jung
KKKwan-Il Kim
Kwan-Il Kim
Hyeung-Jin JangHyeung-Jin Jang
Hyeung-Jin Jang
Acute pneumonia is an inflammatory disease caused by several pathogens, with symptoms such as fever and chest pain, to which children are particularly vulnerable. Gancaonin N is a prenylated isoflavone of Glycyrrhiza uralensis that has been used in the treatment of various diseases in oriental medicine. There are little data on the anti-inflammatory efficacy of Gancaonin N, and its effects and mechanisms on acute pneumonia are unknown. Therefore, this study was conducted as a preliminary analysis of the anti-inflammatory effect of Gancaonin N in lipopolysaccharide (LPS)-induced RAW264.7 cells, and to identify its preventive effect on the lung inflammatory response and the molecular mechanisms underlying it. In this study, Gancaonin N inhibited the production of NO and PGE2 in LPS-induced RAW264.7 cells and significantly reduced the expression of iNOS and COX-2 proteins at non-cytotoxic concentrations. In addition, in LPS-induced A549 cells, Gancaonin N significantly reduced the expression of COX-2 and pro-inflammatory cytokines, such as TNF-α, IL-1β, and IL-6. Moreover, Gancaonin N reduced MAPK signaling pathway phosphorylation and NF-κB nuclear translocation. Therefore, Gancaonin N relieved the inflammatory response by inactivating the MAPK and NF-κB signaling pathways; thus, it is a potential natural anti-inflammatory agent that can be used in the treatment of acute pneumonia.

18 June 2021 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
RKRae Hyung Kang
Rae Hyung Kang
YKYumi Kim
Yumi Kim
JKJi Hyeon Kim
Ji Hyeon Kim
NKNa Hee Kim
Na Hee Kim
HKHyun Min Ko
Hyun Min Ko
Dokyoung KimDokyoung Kim
Dokyoung Kim

Verified
Journal Article
Open access
PDF file
WJWona Jee
Wona Jee
Seung-Hyeon leeSeung-Hyeon lee
Seung-Hyeon lee
HKHyun Min Ko
Hyun Min Ko
Ji Hoon JungJi Hoon Jung
Ji Hoon Jung
WCWon Seok Chung
Won Seok Chung
Hyeung-Jin JangHyeung-Jin Jang
Hyeung-Jin Jang
Obesity is a risk factor for metabolic diseases including type 2 diabetes, nonalcoholic steatohepatitis (NASH), heart diseases, and cancer. This study aimed to investigate the anti-obesity effect of Polygalin C (PC) isolated from Polygala japonica Houtt. in 3T3-L1 adipocytes. Based on Oil Red O assay results, PC significantly decreased lipid accumulation compared to the control. We found that PC suppressed adipogenesis transcription factors including peroxisome proliferator-activated receptor γ (PPAR γ) and CCAAT/enhancer-binding protein (C/EBP) α, and lipogenic factors such as sterol regulatory element-binding protein 1c (SREBP 1c) and fatty acid synthase (FAS), in 3T3-L1 adipocytes using Western blotting and real-time polymerase chain reaction (PCR). Moreover, PC inhibited the differentiation of 3T3-L1 cells by regulating the AMP-activated protein kinase (AMPK)/acetyl-CoA carboxylase (ACC) and mitogen-activated protein kinase/protein kinase B (MAPK/Akt) signaling pathways. Additionally, we confirmed that PC inhibited early adipogenesis factors C/EBP β and C/EBP δ. Therefore, PC inhibited adipogenesis and lipogenesis in vitro. Thus, PC appears to exert potential therapeutic effects on obesity by suppressing lipid metabolism.

14 May 2020 in Molecules
Verified
Journal Article
Open access
PDF file
EAEunJin An
EunJin An
YKYumi Kim
Yumi Kim
Seung-Hyeon leeSeung-Hyeon lee
Seung-Hyeon lee
HKHyun Min Ko
Hyun Min Ko
WCWon Seok Chung
Won Seok Chung
Hyeung-Jin JangHyeung-Jin Jang
Hyeung-Jin Jang
As a plant medicine, Oxalidaceae has been used to treat various diseases in Korea. However, there is little data on the anti-cancer efficacy of Oxalidaceae, particularly O. obtriangulata. This study aimed to investigate the anti-cancer effect of O. obtriangulata methanol extract (OOE) and its regulatory actions on pancreatic carcinoma. OOE showed anti-proliferative effects and induced cell death in the colony formation and cell viability assays, respectively. The Fluorescence-activated cell sorting (FACS) data confirmed that OOE significantly induced cell cycle accumulation at the G2/M phase and apoptotic effects. Additionally, OOE inhibited the activated ERK (extracellular-signal-regulated kinase)/Src (Proto-oncogene tyrosine-protein kinase Src)/STAT3 (signal transducers and activators of transcription 3) pathways including nuclear translocation of STAT3. Furthermore, suppression of Ki67, PARP(Poly ADP-ribose polymerase), caspase-3, P27(Cyclin-dependent kinase inhibitor 1B), and c-Myc as well as the STAT3 target genes CDK(cyclin-dependent kinase)1, CDK2, Cyclin B1, VEGF-1(vascular endothelial growth factor-1), MMP-9(Matrix metallopeptidase 9), and Survivin by OOE was observed in BxPC3. We speculate that these molecular actions might support an anti-cancer effect of OOE. In this study, we demonstrated that OOE may be a promising anti-cancer material and may serve as a natural therapy and alternative remedy for pancreatic cancer treatment.

Verified
Journal Article
Open access
PDF file
Seung-Hyeon leeSeung-Hyeon lee
Seung-Hyeon lee
HKHyun Min Ko
Hyun Min Ko
WJWona Jee
Wona Jee
HKHyungsuk Kim
Hyungsuk Kim
WCWon Seok Chung
Won Seok Chung
Hyeung-Jin JangHyeung-Jin Jang
Hyeung-Jin Jang
Bitter taste receptors (TAS2Rs) are G protein-coupled receptors localized in the taste buds of the tongue. They may also be present in non-lingual organs, including the brain, lung, kidney, and gastrointestinal (GI) tract. Recent studies on bitter taste receptor functions have suggested TAS2Rs as potential therapeutic targets. The human bitter taste receptor subtype hTAS2R50 responds to its agonist isosinensetin (ISS). Here, we demonstrated that, unlike other TAS2R agonists, isosinensetin activated hTAS2R50 as well as increased Glucagon-like peptide 1 (GLP-1) secretion through the Gβγ-mediated pathway in NCI-H716 cells. To confirm this mechanism, we showed that ISS increased intracellular Ca2+ and was suppressed by the IP3R inhibitor 2-APB as well as the PLC inhibitor U73122, suggesting that TAS2Rs alters the physiological state of enteroendocrine L cells in a PLC-dependent manner. Furthermore, we demonstrated that ISS upregulated proglucagon mRNA and stimulated GLP-1 secretion. ISS-mediated GLP-1 secretion was suppressed in response to small interfering RNA-mediated silencing of Gα-gust and hTAS2R50 as well as 2-APB and U73122. Our findings improved the understanding of how ISS modulates GLP-1 secretion and indicates the possibility of using ISS as a therapeutic agent in the treatment of diabetes mellitus.